Sage Therapeutics’ stock slides after biotech says it will cease development of Alzheimer’s treatment
Oct 08, 2024
Sage Therapeutics Inc.’s stock tumbled 12.8% early Tuesday, after the company said a mid-stage trial of a treatment for mild cognitive impairment and mild dementia in Alzheimer’s disease failed to meet its main goal.
https://www.marketwatch.com/story/sage-therapeutics-stock-slides-after-alzheimers-disease-trial-fails-to-meet-main-goal-871723e6?mod=mw_rss_topstories
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service